Cargando…
The Eltrombopag antitumor effect on hepatocellular carcinoma
Currently, sorafenib is the only available chemotherapeutic agent for advanced hepatocellular carcinoma (HCC), but it cannot be used in patients with liver cirrhosis (LC) or thrombocytopenia. In these cases, sorafenib is likely effective if given in combination with treatments that increase the numb...
Autores principales: | KUROKAWA, TOMOHIRO, MURATA, SOICHIRO, ZHENG, YUN-WEN, IWASAKI, KENICHI, KOHNO, KEISUKE, FUKUNAGA, KIYOSHI, OHKOHCHI, NOBUHIRO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599203/ https://www.ncbi.nlm.nih.gov/pubmed/26397763 http://dx.doi.org/10.3892/ijo.2015.3180 |
Ejemplares similares
-
Antisense RNA transcripts in the blood may be novel diagnostic markers for colorectal cancer
por: Kurokawa, Tomohiro, et al.
Publicado: (2017) -
1,8-Cineole Ameliorates Steatosis of Pten Liver Specific KO Mice via Akt Inactivation
por: Murata, Soichiro, et al.
Publicado: (2015) -
The Effect of Three-Dimensional Preoperative Simulation on Liver Surgery
por: Nakayama, Ken, et al.
Publicado: (2017) -
Anticancer effect of linalool via cancer-specific hydroxyl radical generation in human colon cancer
por: Iwasaki, Kenichi, et al.
Publicado: (2016) -
Platelets in liver disease, cancer and regeneration
por: Kurokawa, Tomohiro, et al.
Publicado: (2017)